Form 4 for MRNA Moderna
Accepted 2022-07-22 00:00:00 ET · period of report 2022-07-20 · accession 0001127602-22-019667 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-07-22 | 2022-07-20+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DI | 2022-07-22 | 2022-07-21 | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $165.36 | -10.0K | 6.79M | -0.1% | -$1.65M |
| DM | 2022-07-22 | 2022-07-20+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $167.51 | -80.0K | 5.45M | -1% | -$13.40M |
| DM | 2022-07-22 | 2022-07-20+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.00 | -80.0K | 3.87M | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-20 | M | A | 40,000 | $0.99 | 5,451,946 | D See Footnote | — | — | (F13) These shares are owned directly by OCHA LLC ("OCHA"). The reporting person is the majority equity unit holder and the sole managing member of OCHA. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. |
| 2 | Common | Common Stock | 2022-07-21 | S | D | 10,000 | $165.36 | 6,794,880 | I | — | — | |
| 3 | Common | Common Stock | 2022-07-20 | S | D | 8,838 | $165.50 | 5,439,758 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $164.98 to $165.98. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 4 | Common | Common Stock | 2022-07-20 | S | D | 7,298 | $166.49 | 5,432,460 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $165.99 to $166.98. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 5 | Common | Common Stock | 2022-07-20 | S | D | 12,714 | $167.38 | 5,419,746 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $167.00 to $167.95. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 6 | Common | Common Stock | 2022-07-20 | S | D | 3,915 | $168.77 | 5,415,831 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $168.09 to $169.08. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 7 | Common | Common Stock | 2022-07-20 | S | D | 3,785 | $169.53 | 5,412,046 | D | — | — | (F7) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $169.11 to $170.04. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 8 | Common | Common Stock | 2022-07-20 | S | D | 100 | $170.20 | 5,411,946 | D | — | — | |
| 9 | Common | Common Stock | 2022-07-21 | M | A | 40,000 | $0.99 | 5,451,946 | D | — | — | |
| 10 | Common | Common Stock | 2022-07-21 | S | D | 7,218 | $167.22 | 5,444,728 | D | — | — | (F8) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $166.54 to $167.54. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 11 | Common | Common Stock | 2022-07-21 | S | D | 20,898 | $167.88 | 5,423,830 | D | — | — | (F9) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $167.55 to $168.55. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 12 | Common | Common Stock | 2022-07-21 | S | D | 11,084 | $168.98 | 5,412,746 | D | — | — | (F10) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $168.56 to $169.56. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 13 | Common | Common Stock | 2022-07-21 | S | D | 700 | $169.74 | 5,412,046 | D | — | — | (F11) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $169.57 to $170.43. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 14 | Common | Common Stock | 2022-07-21 | S | D | 100 | $170.75 | 5,411,946 | D | — | — | |
| 15 | Common | Common Stock | 2022-07-20 | S | D | 3,350 | $164.68 | 5,448,596 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $163.97 to $164.96. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 16 | Derivative | Stock Option (Right to Buy) | 2022-07-20 | M | D | 40,000 | $0.00 | 3,907,155 | D | $0.99 · — to 2023-08-19 | 40,000 Common Stock | (F15) This option is fully vested and exercisable. |
| 17 | Derivative | Stock Option (Right to Buy) | 2022-07-21 | M | D | 40,000 | $0.00 | 3,867,155 | D | $0.99 · — to 2023-08-19 | 40,000 Common Stock | (F15) This option is fully vested and exercisable. |